About Trilogy International Partners (TSE:TRL)
Trilogy International Partners Inc, formerly Alignvest Acquisition Corporation, is a Canada-based wireless telecommunications operator. The Company provides wireless communications services through its subsidiaries in New Zealand and Bolivia. Its subsidiaries include Viva and 2degrees. Viva provides voice and a range of data services to its mobile customers over its third generation (3G)-enabled global system for mobile communications (GSM) and fourth generation (4G) long term evolution (LTE) networks. Viva's service offerings include mobile wallet, local and international electronic top-up services, fixed telephony services, and postpaid and prepaid payment options. 2degrees is a full-service communications provider with a fixed broadband solution. 2degrees' services offerings include Voice, data and short messaging service (SMS) over second generation (2G), 3G and 4G; wireless and fixed broadband services; postpaid carryover minutes, and international roaming in over 130 countries.
Industry, Sector and Symbol
Industry Drug Manufacturers - Major
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on Assets-5.37%
Trilogy International Partners (TSE:TRL) Frequently Asked Questions
What is Trilogy International Partners' stock symbol?
Trilogy International Partners trades on the Toronto Stock Exchange (TSX) under the ticker symbol "TRL."
How often does Trilogy International Partners pay dividends? What is the dividend yield for Trilogy International Partners?
Trilogy International Partners declared a quarterly dividend on Wednesday, April 26th. Shareholders of record on Friday, May 12th will be paid a dividend of 0.02 per share on Friday, May 12th. This represents a $0.08 dividend on an annualized basis and a yield of 1.47%. The ex-dividend date is Wednesday, April 26th. View Trilogy International Partners' Dividend History.
Where is Trilogy International Partners' stock going? Where will Trilogy International Partners' stock price be in 2017?
3 brokers have issued 1-year price targets for Trilogy International Partners' stock. Their forecasts range from C$7.00 to C$11.00. On average, they expect Trilogy International Partners' share price to reach C$9.17 in the next year. View Analyst Ratings for Trilogy International Partners.
Who are some of Trilogy International Partners' key competitors?
Some companies that are related to Trilogy International Partners include Mesoblast (MESO), SkyePharma (SKP), Georgia Healthcare Group (GHG), Transenterix (TRXC), Sinovac Biotech (SVA), Atara Biotherapeutics (ATRA), PDL BioPharma (PDLI), Kala Pharmaceuticals (KALA), Aurinia Pharmaceuticals (AUPH), Medical Facilities (DR), Kura Oncology (KURA), Cerus (CERS), Corium International (CORI), Achillion Pharmaceuticals (ACHN), Nantkwest (NK), Corbus Pharmaceuticals (CRBP), Syneron Medical (ELOS) and Mersana Therapeutics (MRSN).
How do I buy Trilogy International Partners stock?
Shares of Trilogy International Partners and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Trilogy International Partners' stock price today?
One share of Trilogy International Partners stock can currently be purchased for approximately C$5.43.
How big of a company is Trilogy International Partners?
Trilogy International Partners has a market capitalization of C$238.23 million.
How can I contact Trilogy International Partners?
Trilogy International Partners' mailing address is 155 108th Ave NE Ste 400, BELLEVUE, WA 98004-8703, United States. The specialty pharmaceutical company can be reached via phone at +1-425-4585900.
MarketBeat Community Rating for Trilogy International Partners (TRL)MarketBeat's community ratings are surveys of what our community members think about Trilogy International Partners and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Trilogy International Partners (TSE:TRL) Earnings History and Estimates Chart
Trilogy International Partners (TSE TRL) Earnings History by Quarter
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Trilogy International Partners (TSE:TRL) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Trilogy International Partners (TSE:TRL) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Trilogy International Partners (TSE TRL) Insider Trading and Institutional Ownership History
Trilogy International Partners (TSE TRL) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|8/13/2015||Nathan John Bryson||Insider||Buy||4,500||C$0.40||C$1,800.00|
|3/24/2015||Tommaso (Tom) Rossi||Insider||Buy||30,000||C$0.82||C$24,600.00|
Trilogy International Partners (TSE TRL) News Headlines
Trilogy International Partners (TSE:TRL) SEC Filings
Financials are not available for this stock.
Trilogy International Partners (TSE TRL) Stock Chart for Tuesday, December, 12, 2017